Statins are potential anticancerous agents (review).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2015.3741PMID 25607255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.

  2014cited by this paper
• Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer.

  2014cited by this paper
• Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.

  2014cited by this paper
• The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy

  2014cited by this paper
• Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

  2014cited by this paper
• HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.

  2014cited by this paper
• Statin use and the risk of breast cancer: a population-based case–control study

  2014cited by this paper
• Use of statins and the risk of death in patients with prostate cancer.

  2014cited by this paper
• Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer

  2014cited by this paper
• HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.

  2014cited by this paper
• Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line

  2014cited by this paper
• Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.

  2014cited by this paper
• Statin Use in Relation to Prostate Cancer Outcomes in a Population‐based Patient Cohort Study

  2013cited by this paper
• Statins and the Risk of Lung Cancer: A Meta-Analysis

  2013cited by this paper
• Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo.

  2013cited by this paper
• Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]

  2013cited by this paper
• Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line

  2013cited by this paper
• Inhibition of Proliferation and Induction of Autophagy by Atorvastatin in PC3 Prostate Cancer Cells Correlate with Downregulation of Bcl2 and Upregulation of miR-182 and p21

  2013cited by this paper
• Statin use and the risk of esophageal cancer: a population-based case-control study

  2013cited by this paper
• Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.

  2013cited by this paper
• Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.

  2013cited by this paper
• Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.

  2013cited by this paper
• Statin Therapy Is Associated With Improved Pathologic Response to Neoadjuvant Chemoradiation in Rectal Cancer

  2013cited by this paper
• Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients

  2013cited by this paper
• Statin use is not associated with reduced risk of skin cancer: a meta-analysis

  2013cited by this paper
• Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway

  2013cited by this paper
• Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.

  2013cited by this paper
• Suppression of interactions between prostate tumor cell‐surface integrin and endothelial ICAM‐1 by simvastatin inhibits micrometastasis

  2013cited by this paper
• HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway

  2013cited by this paper
• Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.

  2013cited by this paper
• Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis.

  2013cited by this paper
• Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway.

  2013cited by this paper
• Statins are associated with reduced risk of gastric cancer: A meta-analysis

  2013cited by this paper
• Statin use in primary inflammatory breast cancer: a cohort study

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma

  2013cited by this paper
• Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.

  2013cited by this paper
• Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age

  2013cited by this paper
• Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.

  2013cited by this paper
• Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells.

  2013cited by this paper
• Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.

  2013cited by this paper
• Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

  2013cited by this paper
• Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway.

  2013cited by this paper
• The effect of statins on risk and survival of gynecological malignancies.

  2013cited by this paper
• Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis.

  2013cited by this paper
• Use of statins and risk of glioma: a nationwide case–control study in Denmark

  2013cited by this paper
• Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL‐KrasG12D‐LSL‐Trp53R172H‐Pdx1‐Cre mice

  2013cited by this paper
• Statin use and risk of bladder cancer: a meta-analysis

  2013cited by this paper
• Statins and primary liver cancer: a meta-analysis of observational studies

  2013cited by this paper
• Statins Reduce Melanoma Development and Metastasis through MICA Overexpression

  2013cited by this paper
• Statin use and the risk of kidney cancer: a population-based case–control study

  2012cited by this paper
• Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts

  2012cited by this paper
• HMG CoA reductase inhibitors, NSAIDs and risk of glioma

  2012cited by this paper
• Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.

  2012cited by this paper
• Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

  2012cited by this paper
• Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non‐small lung cancer cells

  2012cited by this paper
• Statin use and reduced cancer-related mortality.

  2012cited by this paper
• Statin use and risk of breast cancer: a meta-analysis of observational studies

  2012cited by this paper
• Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non‐small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production

  2012cited by this paper
• Statin use and the risk of female lung cancer: a population-based case-control study.

  2012cited by this paper
• Simvastatin downregulates HER2 via upregulation of PEA3 to induce cell death in HER2-positive breast cancer cells.

  2012cited by this paper
• Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells

  2012cited by this paper
• Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells.

  2012cited by this paper
• A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

  2012cited by this paper
• [Effects of simvastatin on PI3K/AKT signaling pathway in human acute monocytic leukemia cell line SHI-1].

  2012cited by this paper
• Statin use and risk of pancreatic cancer: a meta-analysis

  2012cited by this paper
• Statin use and the risk of bladder cancer: a population-based case–control study

  2012cited by this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cited by this paper
• Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies

  2012cited by this paper
• Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

  2012cited by this paper
• Hydrophobic statins induce autophagy and cell death in human rhabdomyosarcoma cells by depleting geranylgeranyl diphosphate.

  2012cited by this paper
• A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancer

  2011cited by this paper
• Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.

  2011cited by this paper
• Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

  2011cited by this paper
• A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

  2011cited by this paper
• Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention

  2011cited by this paper
• Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.

  2011cited by this paper
• Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells

  2011cited by this paper
• Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer

  2010cited by this paper
• The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.

  2010cited by this paper
• Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer

  2010cited by this paper
• Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

  2009cited by this paper
• A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

  2009cited by this paper
• Glioblastoma multiforme: a review of therapeutic targets

  2009cited by this paper
• Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

  2009cited by this paper
• Statins Are Not Associated With a Reduced Risk of Pancreatic Cancer at the Population Level, When Taken at Low Doses for Managing Hypercholesterolemia: Evidence From a Meta-Analysis of 12 Studies

  2008cited by this paper
• Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells.

  2008cited by this paper
• Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.

  2008cited by this paper
• Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma

  2008cited by this paper
• Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.

  2007cited by this paper
• First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma

  2007cited by this paper
• High dose Simvastatin does not reverse resistance to Vincristine, Adriamycin, and Dexamethasone (VAD) in Myeloma

  2007cited by this paper
• Statin drugs and risk of advanced prostate cancer.

  2006cited by this paper
• Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.

  2005cited by this paper
• Lovastatin enhances in vitro radiation-induced apoptosis of rat B-cell lymphoma cells.

  2005cited by this paper
• A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.

  2005cited by this paper
• Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.

  2005cited by this paper
• Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma

  2004cited by this paper
• Mutual amplification of apoptosis by statin‐induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells

  2004cited by this paper

• Intravaginal Phospholipid-anchored Gantrez® Nanoparticles-based Ion-Activated In-Situ Gel for Cervical Cancer Therapy: Simplex-Lattice Mixture Design, Cellular Studies and In-vivo Rat Evaluation

  2026cites this paper
• Evaluating the oncologic impact of statin use in gynecologic cancers: a critical review of pre-clinical and clinical evidence.

  2026cites this paper
• Statin-dye conjugates for selective targeting of KRAS mutant cancer cells

  2026cites this paper
• Impact of statin use on survival and adverse events in patients with cancer receiving radiotherapy: a systematic review and meta-analysis

  2025cites this paper
• Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach

  2025cites this paper
• Herbo-Mineral Medicine, Cardiogrit Gold, Exhibits Protective Effects in Caenorhabditis elegans Model of Doxorubicin-Induced Cardiotoxicity

  2025cites this paper
• Statin-dye conjugates for selective targeting of KRAS mutant cancer cells

  2025cites this paper
• Temperature-induced phase transitions in atorvastatin calcium trihydrate revealed by low-energy raman analysis

  2025cites this paper
• Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions

  2025cites this paper
• Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.

  2024cites this paper
• In vitro antitumor efficacy of atorvastatin against acute monocytic leukemia cells

  2024cites this paper
• Synergistic antitumor effects of atorvastatin and chemotherapies: In vitro and in vivo studies.

  2024cites this paper
• Efficacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis

  2024cites this paper
• Preoperative metabolic syndrome and prognosis after pancreatectomy for pancreatic cancer: A retrospective study.

  2024cites this paper
• Statin therapy enhances survival in unresectable stage III lung squamous cell carcinoma with concurrent chemoradiotherapy.

  2024cites this paper
• Red Blood Cell-Hitchhiking Delivery of Simvastatin to Relieve Acute Respiratory Distress Syndrome

  2024cites this paper
• Statins as anti‐tumor agents: A paradigm for repurposed drugs

  2024cites this paper
• Antitumor efficacy of atorvastatin in lung cancer mice model

  2024cites this paper
• Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases.

  2024cites this paper
• Statin Use During Concurrent Chemoradiotherapy with Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched Nationwide Cohort Study.

  2023cites this paper
• Pitavastatin induces caspase‐mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line

  2023cites this paper
• Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer

  2023cites this paper
• Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin.

  2023cites this paper
• The effects of statin therapy on brain tumors, particularly glioma: a review

  2023cites this paper
• The roles of ATP‐binding cassette transporter A1 and its substrate cholesterol in head and neck cancers

  2023cites this paper
• Advances in ovarian cancer treatment using a combination of statins with other drugs

  2023cites this paper
• Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea

  2022cites this paper
• Identification of foods that affect the anti-cancer activity of pitavastatin in cells.

  2022influential citation
• ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

  2022cites this paper
• A method of isolating and analysing drugs from cancer cells for preclinical research.

  2022cites this paper
• Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials

  2022cites this paper
• Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors

  2022cites this paper
• Simvastatin Inhibits Tumor Growth and Migration by Mediating Caspase-1-dependent Pyroptosis in Glioblastoma Multiforme.

  2022cites this paper
• Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.

  2022cites this paper
• Effects of Statins on the Incidence and Mortality of Sepsis in Patients with New Cancer Diagnosis

  2021cites this paper
• Cytotoxic activity of cholesterol oxidase produced by Streptomyces sp. AKHSS against cancerous cell lines: mechanism of action in HeLa cells

  2021cites this paper
• The antagonistic atorvastatin-glibenclamide interactions suppressed the atorvastatin-induced Bax/cytochrome c/p53 mRNA expressions and increased Rho A mRNA expression in B16f10 melanoma cell culture

  2021cites this paper
• Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy

  2021cites this paper
• Antiangiogenic and Proapoptotic Activities of Atorvastatin and Ganoderma lucidum in Tumor Mouse Model via VEGF and Caspase-3 Pathways

  2021cites this paper
• Prevention of hepatitis B virus-related hepatocellular carcinoma

  2021cites this paper
• Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

  2021cites this paper
• Rosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via Autophagy

  2021cites this paper
• DDDT_A_344052 5135..5150

  2021cites this paper
• Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells

  2021cites this paper
• A Phase III Randomized Clinical Trial Study of Chemoradiation using Lovastatin/Cisplatin in Patients with Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Crosstalk between Statins and Cancer Prevention and Therapy: An Update

  2021cites this paper
• Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation

  2021cites this paper
• Fursultiamine Prevents Drug-Induced Ototoxicity by Reducing Accumulation of Reactive Oxygen Species in Mouse Cochlea

  2021cites this paper
• Effects of sublethal concentration of metamifop on hepatic lipid metabolism in adult zebrafish (Danio rerio).

  2021cites this paper
• Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis

  2020cites this paper
• The ABC subfamily A transporters: multifaceted players with incipient potentialities in cancer.

  2020cites this paper
• Selected pharmacotherapy agents as antiproliferative and anti‐inflammatory compounds

  2020cites this paper
• Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence

  2020cites this paper
• Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.

  2020cites this paper
• Associations among statins, preventive care, and prostate cancer mortality

  2020cites this paper
• Repurposing of drugs approved for cardiovascular diseases: opportunity or mirage?

  2020cites this paper
• Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis

  2020cites this paper
• A remarkable in vitro cytotoxic, cell cycle arresting and proapoptotic characteristics of low-dose mixed micellar simvastatin combined with alendronate sodium

  2020cites this paper
• Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.

  2020cites this paper
• Targeting the Mevalonate Pathway Enhances the Efficacy of Epidermal Growth Factor Receptor – Tyrosine Kinase Inhibitors in Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo

  2020cites this paper
• Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study

  2020cites this paper
• Pleiotropic effects of statins: a focus on cancer.

  2020cites this paper
• Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study

  2020cites this paper
• Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies

  2020cites this paper
• Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes

  2020cites this paper
• Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork

  2020cites this paper
• Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells

  2020cites this paper
• Clinical trials on combination of repurposed drugs and anticancer therapies

  2020cites this paper
• CMAR_A_247876 4645..4665

  2020cites this paper
• 1 Repurposing of drugs approved for cardiovascular diseases : opportunity or mirage ?

  2020influential citation
• Validation of human sterol 14α-demethylase (CYP51) druggability: structure-guided design, synthesis and evaluation of stoichiometric, functionally irreversible inhibitors.

  2019cites this paper
• Drug Repurposing in the Development of Anticancer Agents.

  2019cites this paper
• Molecular Carcinogenesis

  2019cites this paper
• Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.

  2019cites this paper
• Statins: Complex outcomes but increasingly helpful treatment options for patients.

  2019cites this paper
• Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways

  2019cites this paper
• A systematic review and meta-analysis

  2019cites this paper
• The association between statin use and survival of esophageal cancer patients

  2019cites this paper
• Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death

  2019cites this paper
• A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)

  2019cites this paper
• An overview of the bioactivity of monacolin K / lovastatin.

  2019cites this paper
• Ferroptosis suppressed the growth of melanoma that may be related to DNA damage

  2019cites this paper
• Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs

  2019cites this paper
• The risk of cancer in statin users : a clinical and genetic approach

  2019cites this paper
• Statins: A Conceivable Remedial Role for the Regulation of Cancer Progression

  2019cites this paper
• Repurposing drugs for the treatment of glioma

  2019cites this paper
• Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery

  2019cites this paper
• Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells

  2019cites this paper
• Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer

  2018cites this paper
• Metabolic networks in ferroptosis.

  2018cites this paper
• Simvastatin targets pancreatic cancer stem-like cells and sensitizes PDA cells to chemotherapeutic drugs via sonic hedgehog signaling

  2018cites this paper
• Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases.

  2018cites this paper
• Statins: a new approach to combat temozolomide chemoresistance in glioblastoma

  2018cites this paper
• Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia

  2018cites this paper
• Loading Lovastatin into Camptothecin-Floxuridine Conjugate Nanocapsules for Enhancing Anti-metastatic Efficacy of Cocktail Chemotherapy on Triple-negative Breast Cancer.

  2018cites this paper
• The poor design of clinical trials of statins in oncology may explain their failure - Lessons for drug repurposing.

  2018cites this paper
• Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study

  2018cites this paper
• Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target

  2018cites this paper